ACOG. (2013) Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians and Gynecologists. Obstetrics and Gynecology121: 891896. doi: 10.1097/01.AOG.0000428646.67925.9a.
2.
BhattacharyaS.MiddletonL. J.TsourapasA.LeeA. J.ChampaneriaR.DanielsJ. P.ZupiE. (2011) Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review. Health Technology Assessment15(19): iiixvi, 1–252. doi: 10.3310/hta15190.
3.
DavisS. I.BlanckH. M.HertzbergV. S.TolbertP. E.RubinC.CameronL. L.MarcusM. (2005) Menstrual function among women exposed to polybrominated biphenyls: A follow-up prevalence study. Environmental Health: A Global Access Science Source4: 15doi: 10.1186/1476-069X-4-15.
4.
Lethaby, A., Duckitt, K., & Farquhar, C. (2013). Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, 1, Art. No. CD000400. doi: 10.1002/14651858.CD000400.pub3.
5.
MareshM. J.MetcalfeM. A.McPhersonK.OvertonC.HallV.HargreavesJ.CasbardA. (2002) The VALUE national hysterectomy study: description of the patients and their surgery. British Journal of Obstetrics and Gynaecology109: 302312. doi: 10.1111/j.1471-0528.2002.01282.x.